U.S. drug price cuts proposed by Trump cause initial dip then rebound in Indian pharma stocks.

Indian pharmaceutical stocks initially fell on May 12 after U.S. President Donald Trump announced plans to cut U.S. drug prices by up to 80%. The Nifty Pharma index dropped but later rebounded over 2.5%, closing at 21,047. Trump's "Most Favored Nation" policy aims to align U.S. drug prices with the lowest prices globally, potentially raising drug costs in markets like India. Despite concerns, the recovery shows investor faith in India's pharma sector's adaptability.